October 09, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee surgery implants, is today announcing its revenue for the third quarter and for the nine-month period ended September 30, 2018. Implanet is holding a conference call […]